SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-052797
Filing Date
2020-10-01
Accepted
2020-10-01 21:29:32
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6338
2 POA DOCUMENT poa.txt EX-24.3_939431 3600
  Complete submission text file 0001209191-20-052797.txt   11304
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341
Business Address
Lefenfeld Michael (Reporting) CIK: 0001826906 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39580 | Film No.: 201217895